PANCREAS CANCER
Clinical trials for PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental pancreatic cancer combo trial halted early
Disease control TerminatedThis early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) could help people with metastatic pancreatic cancer. Only 4 people took part before the study was stopped. The goal was to find a safe dose and see if the combination c…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
Experimental cancer drug study halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The goal was to find safe doses and see if the combination worked better. The study was…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC